62OTepotinib in NSCLC patients harboring METex14 skipping:...

Annals of Oncology 2019 / 11 Vol. 30; Iss. Supplement

62OTepotinib in NSCLC patients harboring METex14 skipping: Cohort A of phase II VISION study

Park, K, Felip, E, Veillon, R, Cortot, A, Mazieres, J, Sakai, H, Reinmuth, N, Viteri, S, Chen, Y-M, Han, J-Y, Jang, T-W, Morise, M, Sakamoto, T, Tokito, T, Cho, B C, Bruns, R, Scheele, J, Straub, J, L
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz420.001
Date:
November, 2019
File:
PDF, 118 KB
2019
Conversion to is in progress
Conversion to is failed